Latest filing published 07 Jul 2025 for MoonLake Immunotherapeutics.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Catherine Moukheibir: trading record in brief
Filings by Catherine Moukheibir span 2 companies, the busiest being Ironwood Pharmaceuticals Inc and MoonLake Immunotherapeutics. We count 21 filings; the first trade dates from 1 April 2019 and the latest from 3 July 2025.
No open-market purchase appears, only 3 sales worth €1.4M. Outside the open market, there are 17 share grants and 1 option exercise. So far in 2025, the count stands at no purchases and 1 sale.
On 7 July 2025 came the latest disclosure, an open-market sale for €974k in MoonLake Immunotherapeutics. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Catherine Moukheibir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,500 shares0Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-061752:0
- 45,000 shares0Class A Common StockSEC:0000950170-25-085446:0
- 24,311 shares0Class A Common StockSEC:0000950170-24-076220:0
- 44,426 shares@ US$6.36100.0% of flowClass A Common StockSEC:0000950170-24-071393:0
- 1,572 shares0Class A Common StockSEC:0001209191-23-059113:0
- 2,098 shares0Class A Common StockSEC:0001209191-23-049998:0
- 22,350 shares0Class A Common StockSEC:0001209191-23-039142:0
- 1,586 shares0Class A Common StockSEC:0001209191-23-038340:0
- 1,677 shares0Class A Common StockSEC:0001209191-23-019597:0
- 21,571 shares0Class A Common StockSEC:0001209191-22-033969:0
- 1,466 shares0Class A Common StockSEC:0001209191-22-019522:0
- 1,541 shares0Class A Common StockSEC:0001209191-21-070230:0
- 1,447 shares0Class A Common StockSEC:0001209191-21-056657:0
- 1,565 shares0Class A Common StockSEC:0001209191-21-040924:0
- 22,766 shares0Class A Common StockSEC:0001209191-21-038205:0
15 of 15 declarations
